After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team is changing the acceptable shipping conditions for samples requiring this test. Effective immediately, samples requiring Monolisa anti-HBs EIA testing must be shipped directly to Special Testing in CTS Phoenix at 2-8 C using wet ice or frozen using dry ice.
Samples submitted to CTS in the routine donor sample shipper will be deemed unacceptable for the Monolisa anti-HBs EIA test. If you have questions, contact your Customer Service Manager.
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...